coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    West Knowsley PCN, Knowsley (LAD) · Health Inequalities Profile

    PCN U37296 · NHS Cheshire and Merseyside Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    50,265

    Registered population

    61.5% aged 18–64

    17.7%

    Aged 65+

    ICB 19.0% · England 17.9%

    5.8%

    Ethnic minority (non-White)

    2.3% Asian · England 9.6%

    58.9%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~26,246

    Core20 residents (est.)

    Resident basis; registered basis ~30,712 · see page 3

    8,773

    Hypertension register

    +4.56% in 3 yrs · England +5.60%

    699

    SMI register

    35.7% of Knowsley (LAD)'s

    1,821

    COPD register

    Reviews +54.65% in 3 yrs

    Forecast to 2030

    9,682

    Hypertension patients, 2030

    +909 on today

    68.8%

    QRISK ≥20% on statins, 2030

    +3.57pp over 3 yrs

    4.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    +54.6%
    Rapid three-year gains in long-term condition reviews.

    Over 2023 to 2025, annual review coverage rose +54.6% in COPD to 79.2% (England 76.4%), alongside gains in heart failure (+51.4%) and asthma (+47.6%).

    1,140
    Unreviewed asthma cohort alongside high paediatric prescribing.

    At 66.2% review coverage across 3,377 asthma patients, about 1,100 lack a recorded review, while age 5-19 prescribing is 3,415 per 1,000 (England 1,488).

    66.9%
    Cardiovascular and SMI treatment indicators trail England.

    Hypertension treated to threshold (66.9% vs 70.3% in England), QRISK >= 20% lipid therapy (61.0% vs 63.6%) and SMI BP checks (80.1% vs 83.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Registered patients include 10,466 children and 8,891 older adults alongside 27 catchment care homes

    West Knowsley PCN serves 50,265 registered patients. Registered children aged 0-17 comprise 20.8% (10,466 patients), compared with 21.1% in Knowsley, 19.2% in the ICB, and 19.6% in England. Registered adults aged 65+ represent 17.7% (8,891 patients; England 17.9%, Knowsley 16.9%, ICB 19.0%). Census usual residents in associated areas are 94.2% White, against 95.3% in Knowsley, 93.0% in the ICB, and 81.1% in England, giving a 5.8% ethnic minority share. Resident Census geography does not represent registered patients.

    Age profile

    0–1720.8%
    18–6461.5%
    65+17.7%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White94.2%
    Asian2.3%
    Mixed1.8%
    Black1.0%
    Other0.7%

    Older people · falls rows are Knowsley (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Knowsley LA)2,7842,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.3%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Knowsley LA)1,4401,0219552024/25
    Falls deaths, all ages, per 100,000 (Knowsley LA)23.118.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 patients comprise 58.9% PCN-wide, spanning 40.9% to 88.6% across practices

    West Knowsley PCN records an average IMD decile of 3.1, with 58.9% of registered patients in the Core20 cohort (England 21.0%, Knowsley 52.5%, ICB 31.9%). Practice deprivation spans 47.7 pp: Colby Medical Centre (88.6%) and Primrose Medical Practice (88.4%) lead in concentration, while Cornerways Medical Centre (11,659 estimated patients) and Aston Healthcare Limited (6,731 estimated patients) have the largest volumes. Weighted practice share is 61.1%, differing from the PCN rate by 2.19 percentage points. Dual allocation across high-concentration practices and high-volume lists can address distinct Core20 workload demands.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Colby88.6% · 2,097 patients
    Primrose Medical88.4% · 2,256 patients
    Cornerways81.6% · 11,659 patients
    Hillside House77.4% · 2,181 patients
    Roseheath51.7% · 3,681 patients
    The45.0% · 2,107 patients
    Aston Healthcare40.9% · 6,731 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    699

    SMI register

    1.35% recorded prevalence

    326

    Learning disability register

    0.63% recorded prevalence

    27

    Care homes, 1,196 beds

    In the PCN catchment

    11.5%

    Provide unpaid care

    Knowsley (LAD), Census 2021

    The PCN records 699 severe mental illness patients (1.4% prevalence; England 1.0%, Knowsley 1.2%, ICB 1.1%) and 326 on the learning disability register (0.6%; England 0.6%, Knowsley 0.7%, ICB 0.6%). PCN catchment services contain 27 care homes with 1,196 beds, though bed capacity does not establish occupancy or registered resident counts. The severe mental illness register sits above England, so physical-health checks for this group are the larger inclusion-health workload.

    Severe mental illness: physical health checks

    On the SMI register (699 patients; 1.4% prevalence), 80.1% had a blood pressure check, trailing England (83.4%), despite 95.3% having BMI recorded. Prioritising blood pressure checks during routine reviews could close this cardiovascular monitoring gap.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,773

    Hypertension register

    +4.56%

    Register growth, 3 yrs

    Knowsley (LAD) +5.44% · England +5.60%

    +16.59pp

    BP control, under 80

    ≤140/90 · +9.81pp aged 80+

    +909

    More patients by 2030

    Forecast 9,682 (18.56%)

    Hypertension case-finding and control

    Hypertension prevalence is 17.0% (8,773 patients), above England (15.2%), Knowsley (16.7%) and the ICB (16.8%), though the register's implied base (51,667) exceeds the 50,265 list size. Recent blood pressure monitoring reached 89.4% (England 90.0%). Despite a 3-year gain of +14.9 pp (England +2.5 pp), treatment to target sits at 66.9%, trailing England (70.3%), Knowsley (69.6%) and the ICB (69.1%). Control trails across age cohorts: under-80 control is 64.8% (England 67.8%) and aged 80+ control is 76.7% (England 81.2%). Blood pressure control trails national benchmarks across both age cohorts despite near-benchmark monitoring, prioritizing systematic medication titration and recall to close the management gap.

    Lipids and statins

    Lipid therapy reaches 61.0% of patients with QRISK ≥ 20%, trailing England (63.6%), Knowsley (64.0%) and the ICB (63.2%). Statin coverage in diabetes without CVD is 70.8% (England 73.2%). Fewer at-risk patients receive lipid-lowering therapy than England rates imply, indicating scope for systematic recall across primary prevention cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026110,802£1.70£1.71£1.86£188,363
    Cardiovascular (all), 2025162,405£3.88£4.37£3.33£630,131

    In 2026, lipid-modifying drugs cost £1.70 per item across 110,802 items, compared with £1.86 in England, £1.63 in Knowsley and £1.71 in the ICB. The PCN spent £17,728 less than at England's unit cost. Lower unit cost than England does not establish formulary efficiency, but indicates existing prescribing expenditure across high-volume lipid items.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +47.64%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.20%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 3.5% (1,821 patients), above England (1.9%), though the register fell 3.7% over 2023 to 2025 (England +2.6%). Reviews reached 79.2% in COPD and 66.2% in asthma (3,377 patients; England 65.7%), leaving about 1,100 asthma patients unreviewed. Alongside this, paediatric asthma prescribing reached 3,415 items per 1,000 aged 5-19 against England's 1,488 rate. High prescribing alongside unreviewed asthma patients suggests an opportunity to audit inhaler regimens and target structured annual reviews.

    Cancer register and children's immunisation

    Cancer prevalence is 3.6% (1,847 patients), below England (3.8%). In Q1 2025/26, childhood immunisations trailed the 95% target: 24-month MMR1 was 72.7% (22.3 pp below target; England 88.3%) and age-5 MMR2 was 73.5% (21.5 pp below target; England 82.8%). At age 5, the MMR dose difference was 10.6 pp across the PCN. Lower uptake leaves cohorts vulnerable, making second-dose recall and outreach a critical paediatric priority.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months81.0%

    England 91.0%

    6-in-1 complete primary course at 24 months75.3%

    England 92.2%

    MMR dose 1 at 24 months72.7%

    England 88.3%

    MMR dose 2 at age 573.5%

    England 82.8%

    4-in-1 pre-school booster at age 572.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, 55.5% of staged cancers in NHS Cheshire and Merseyside ICB (7,482 of 13,490) were stage 1 or 2, against England (55.3%) and 19.5 pp below the 75.0% national ambition by 2028, requiring about 2,640 extra early-stage cases annually. Known-stage share was 72.8% (13,490 of 18,522). This wider-system data was not captured at PCN level. Locally, PCN breast screening was 63.7% (England 69.9%; ICB 72.0%), and cervical screening was 65.3% (England 66.8%) after falling 5.1% over 2023 to 2025 (England -1.0%). Persistent screening shortfalls may delay early detection, making proactive recall a PCN priority.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Mersey and West Lancashire Teaching Hospitals NHS Trust met the 62-day referral to treatment standard for 78.0% of pathways (309.5 of 397), 7.0 pp below the 85.0% standard, but above England (71.2%), Liverpool University Hospitals NHS Foundation Trust (73.3%) and the ICB (76.2%), though behind North Cheshire and Mersey NHS Foundation Trust (83.7%). On the 28-day faster diagnosis standard, the trust achieved 72.4% (2,790 of 3,854) against the 75.0% standard, trailing the ICB (77.2%) and England (79.3%). These provider metrics describe wider acute performance.

    Pathways within standard (%)Mersey and West LancashireLiverpoolNorth Cheshire and MerseyCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)72.3975.4780.2177.2579.32
    31-day treatment (96%)95.4690.5198.1795.7192.50
    62-day referral to treatment (85%)77.9673.2683.6776.2371.16
    Diagnostic waits over 6 weeks (%)Mersey and West LancashireLiverpoolNorth Cheshire and MerseyEngland
    MRI14.046.420.5321.40
    CT13.080.712.329.92
    Echocardiography34.8812.5528.0428.48
    Colonoscopy18.0433.1415.9830.83
    Gastroscopy18.1744.9920.2429.02
    All 15 DM01 tests21.1711.506.3423.14
    Community services activityKnowsley residentsCheshire and Merseyside ICB
    Care contacts45,655541,280
    Referrals8,47597,150
    Patients with a contact12,490146,240

    Community services (residents of Knowsley), Jun 2026 (provisional). In Jun 2026 (provisional), community health service activity recorded across Knowsley borough residents totalled 45,655 contacts. Adults aged 65 and over accounted for 57.9% of these contacts (26,435). These figures from the Community Services Dataset reflect wider borough resident activity rather than West Knowsley PCN registered-patient contacts, highlighting substantial older-adult community demand across the borough.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient experience varies sharply across practices, with phone access spanning 43.1 percentage points

    In 2025/26, overall QOF achievement spanned from 81.9% at Hillside House Surgery to 88.7% at Primrose Medical Practice, trailing England (92.5%). All seven practices scored 15.6% in vaccination and immunisation against England's 55.2%, whereas clinical domain achievement remained resilient, reaching 89.7% to 97.7% (England 97.1%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    The12045.077.9%67.8%92.9%
    Primrose Medical13888.472.1%76.1%83.3%
    Colby10888.684.8%71.2%82.1%
    Hillside House11777.469.7%78.0%78.5%
    Cornerways10381.641.8%70.1%75.6%
    Roseheath Surgery8951.752.6%80.7%66.5%
    Aston Healthcare8540.944.5%83.0%63.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNKnowsley (LAD)AssetPCNKnowsley (LAD)
    Care homes (catchment)27 (1,196 beds)n/aSchools (catchment)110n/a
    Children's centres1115Places of worship2748
    Libraries33Primary schools (LA maintained)2032
    Primary academies1213Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and inhaler recall

    Out of 3,377 asthma register patients, 66.2% had a review (England 65.7%), leaving 1,140 (about 1,100) unreviewed, while prescribing is 3,415 items per 1,000 aged 5-19 (England 1,488). For discussion: run a structured asthma recall combining annual review templates with inhaler prescribing checks, offering after-school slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Hypertension titration and lipid recall

    Hypertension treatment to target is 66.9% (England 70.3%; under-80s 64.8% vs 67.8%; 80+ 76.7% vs 81.2%) on an 8,773 register, and lipid therapy for QRISK ≥ 20% is 61.0% (England 63.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    SMI physical health check completion

    On the 699-patient SMI register (1.4% prevalence; 35.7% of the Knowsley register), blood pressure check completion is 80.1%, trailing England (83.4%), Knowsley (82.5%) and the ICB (81.3%), despite 95.3% BMI recording. Low cost, quick to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Dual-track Core20 allocation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Severe mental illness blood pressure recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension titration and recall review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation call and recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Primary care access and telephony review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma review and inhaler recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Hypertension titration and lipid recall (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · SMI physical health check completion (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15